• Why are A2 Milk shares sinking 18% today?

    Woman with a concerned look on her face holding a credit card and smartphone.

    A2 Milk Company Ltd (ASX: A2M) shares are on the slide on Monday morning.

    In early trade, the ASX 200 stock is down 18% to $7.57.

    Why is this ASX 200 stock crashing today?

    The infant formula company’s shares are under pressure today following the release of a trading, supply chain, and outlook update.

    According to the release, while demand for its products remains strong, A2 Milk is experiencing significant supply chain disruptions that are expected to impact its FY 2026 performance.

    The ASX 200 stock revealed that it is currently facing temporary product availability issues in China, particularly for its China label infant milk formula (IMF) products.

    These issues have been driven by a combination of factors, including strong demand, freight disruptions, production constraints, and longer product release and customs clearance times.

    Management notes that freight capacity has been impacted by the Middle East conflict, while production has been constrained due to earlier manufacturing challenges and a backlog of orders.

    As a result, the company expects these issues to materially impact product availability during the fourth quarter, particularly across April and May.

    Guidance downgraded

    Due to these challenges, A2 Milk has downgraded its FY 2026 outlook, putting significant pressure on its shares.

    The ASX 200 stock now expects revenue growth in the low to mid double-digit range, which is down from its previous guidance of mid double-digit growth.

    In addition, EBITDA margins are now expected to be between 14% and 14.5% in FY 2026. This compares to its prior guidance of 15.5% to 16%.

    As a result, the company’s net profit after tax is now expected to be similar to or lower than in FY 2025, whereas previously it had been forecast to grow.

    Cash conversion is also expected to fall significantly to around 50%, down from prior expectations of 80%.

    Commenting on the situation, the ASX 200 stock said:

    While the supply chain impacts are primarily timing-related and one-off in nature, their cumulative effect is now expected to impact the Company’s performance against FY26 guidance, noting their potential impacts are challenging to mitigate at this stage in the financial year due to proximity to year end and end-to-end supply chain lead times.

    Notwithstanding these short term challenges, the Company intends to continue to reinvest in the business in 4Q26 to support brand health, growth and long term value creation.

    The post Why are A2 Milk shares sinking 18% today? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in The a2 Milk Company Limited right now?

    Before you buy The a2 Milk Company Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and The a2 Milk Company Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why are Pro Medicus shares outperforming the market on Monday?

    Ecstatic woman looking at her phone outside with her fist pumped.

    Pro Medicus Ltd (ASX: PME) shares are catching the eye of investors on Monday.

    In morning trade, the health imaging technology company’s shares are up 2% to $129.80.

    This compares favourably to the performance of the ASX 200 index, which is down 0.6% at the time of writing.

    Why are Pro Medicus shares charging higher?

    Investors have been bidding the company’s shares higher today after it announced another major contract win.

    According to the release, its wholly owned U.S. subsidiary, Visage Imaging, has signed a five-year contract renewal with Northwestern Medicine.

    It notes that Northwestern Medicine is a premier academic health system based in Chicago, featuring top-ranked hospitals, including Northwestern Memorial Hospital, and over 200 sites across Illinois.

    It is also the primary teaching affiliate for the Northwestern University Feinberg School of Medicine.

    The contract is valued at $37 million and is for its leading Visage 7 Viewer. Importantly, management highlights that the renewal has been negotiated with increased minimums and an increased fee per transaction. This should be a big confidence builder given how some bears believe that artificial intelligence (AI) will drive down the prices that software companies can command.

    It also notes that the contract is transaction-based with potential upside beyond the $37 million.

    Commenting on the news, Pro Medicus’ CEO, Dr Hupert, said:

    We are extremely pleased that in addition to committing to a second five-year term at an increased fee per exam, NM have also committed to an increase in their minimums reflecting the growth in their exam volumes since standardising on our platform five years ago.

    In the last month we have contracted nearly $80 million in renewals maintaining our track record when it comes to client retention. This underpins our belief that our solution provides unparalleled return on investment from both a financial and clinical perspective.

    Busy period

    As mentioned above, this is the second contract announcement in as many weeks.

    Last week, Pro Medicus signed a five-year contract with the University of Maryland Medical System that is worth $23 million.

    That contract, also based on a transactional licensing model, will see the company’s cloud-based Visage 7 Enterprise Imaging Platform implemented across the University of Maryland Medical System, providing a unified enterprise imaging platform for diagnostic interpretation.

    The post Why are Pro Medicus shares outperforming the market on Monday? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Pro Medicus right now?

    Before you buy Pro Medicus shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • What the basketball GOAT can teach investors

    A businessman keeps calm in the face of inflation, holding a basketball.

    I was listening to an audiobook by comedian Jimmy Carr over the weekend.

    In it, amongst the jokes and advice, was a reminder of a quote I’ve long appreciated, from basketball legend, Michael Jordan:

    “I’ve missed more than 9,000 shots in my career. I’ve lost almost 300 games. 26 times, I’ve been trusted to take the game-winning shot and missed. I’ve failed over and over and over again in my life. And that is why I succeed”

    Now, writers like nothing better than a nice little sports metaphor. They’re understandable, and relatable.

    No, sorry, there’s no ‘but’ here.

    I like them, too.

    I mean, they’re not perfectly analogous, for more than a few reasons, but they’re also not not analogous.

    And I particularly like them as an investing analogy when it comes to the topic of Jordan’s quote: failure and success.

    I’ve used a football match as an analogy before, to illustrate something similar.

    See, even the best teams miss tackles.

    Even the best teams concede tries and goals.

    Even the best teams lose games.

    Even the best teams have losing streaks.

    Even the best teams have poor seasons.

    It goes further, though.

    The best teams often aren’t the best teams for long stretches.

    Sometimes years on end.

    See, they’re not the best teams because they never lose. They’re the best teams because they lose less often – and therefore win more often – than the other teams, on average, over a long period of time.

    Oh sure, there’s a ‘best team’ in each competition, right now. They’re the ones on top of the respective ladders/tables.

    There is a ‘best team’ of the last year, too.

    And the last five years.

    Though at this point, it gets kinda arguable.

    Go to 10 years and you have the making of a weekend afternoon-long debate.

    But statistically, I reckon you can still pick, if not the best single team, the best two or three.

    And when you do, you’ll find something really interesting.

    You stop talking about this weekend’s game. Or last year’s premiers.

    You start talking about teams (clubs, really, because most players will have moved on inside a decade) that have something different.

    Not the best player (though that helps) or the right tactics (ditto).

    You end up talking about the structural stuff that matters more. That allows success to be enduring. No, not always ending in a premiership every year, but an approach that makes success more likely than not, and that delivers an above average performance, over the long term.

    If your preferred sport doesn’t have a salary cap, you’re thinking about their financial firepower. If it does, things like the ‘back office’, club culture and other non-monetary differentiators come to mind.

    But those all fall under ‘strategy’ not ‘tactics’. The aim is of course to win as many battles as possible, but the broader aim is to win the war.

    (The only thing that rivals sports metaphors? Military ones. Let the court-martial begin. Guilty as charged!)

    The strategy that makes long term success more likely will almost certainly also result in more individual games being won. But not all of them.

    And it won’t deliver success every year, either.

    But, considered carefully, codified cleverly, and executed faithfully, the right strategy will earn more than its fair share of success.

    Which is where I want to return to investing.

    Warren Buffett didn’t have many bad years, in six decades in charge of Berkshire Hathaway (I own shares). But he had some.

    Not because his strategy was wrong, but because sometimes the circumstances were such that it didn’t prevail in the short term.

    During the dot.com boom, index investors left Buffett’s returns for dead. Tech investors did even better. But he didn’t change his approach. He didn’t abandon his strategy.

    He just accepted that it wasn’t delivering in the short term, during that time.

    Over time? You won’t be surprised to know that Buffett had the last laugh.

    The key was not trying to adjust his approach just because he’d had a few losses in a row.

    It was the opposite: sticking to what he was convinced would work in the long term.

    Not being scared, impatient, impulsive or listening to those, like the headline writer, who (in)famously asked ‘What’s Wrong, Warren?’.

    It can’t have been easy. I mean the man is Warren Buffett for goodness sake. He’s the bloke with the reputation as the ‘Oracle of Omaha’.

    So publicly trailing the market must have been really tough.

    No-one likes to be perceived as – or to feel like – a loser.

    Just ask those footy teams who punt their coaches or managers a few games into a new season.

    It’s madness, of course: this was apparently the right bloke only 6 weeks ago, and now he’s totally unsuited to the role? Really?

    Generously, maybe the club bosses just realised they made an error appointing (or reappointing) the bloke as coach.

    Realistically? They just hated losing (who doesn’t?) and couldn’t trust the(ir own!) process. They just felt like they had to do something. Anything!

    They would, in all likelihood, make terrible investors.

    If you buy shares, and sell them six weeks later because they’re not ‘winning’ yet, you’re not an investor. You’re not even a gardener. You’re barely a house painter!

    I’m not sure what outcomes in life you can reliably expect will unfold in six weeks, especially when you’re competing against others – and the fickle finger of fate – but I suspect there aren’t many, and they’re unlikely to be consequential.

    The real successes, though? The long term ones?

    Almost without exception they come from understanding what combination of factors tend to result in long term success, then doing those things, repeatedly, consciously, faithfully, over time.

    Even though the results may not be known for years.

    And… accepting that they won’t always be enough.

    Crucially, though, remembering that at those particular times, a  kneejerk change of course will probably feel better (‘Just make the pain stop, please!’), but probably at the expense of long term success.

    Or, at the very least, leaving that success up to chance, on the basis that if you change enough, often enough, maybe, eventually, you’ll get lucky.

    That’s not how the good teams building winning cultures, or long term success.

    Jordan didn’t change his technique every time he missed a shot… even when he cost his team a game.

    Oh, sure he constantly tried to learn and improve, but that, itself, is a strategy.

    But also, while bitterly disappointed, he trusted the process. Remember the last sentence of that quote:

    “… I’ve failed over and over and over again in my life. And that is why I succeed”

    He didn’t succeed because of a lack of failure. He succeeded because of that failure.

    I can’t tell you how many would-be or one-time investors I’ve heard of, or from, who bought one, or two, or three stocks and, dejected because they weren’t immediate successes, threw the whole thing away.

    (I do know they’re the vocal ones on social media or in chat rooms, telling anyone who’ll listen that ‘this whole thing is a scam’!)

    They don’t realise how close they got. And what they’re throwing away because they missed a single game-winning shot.

    Jordan never stopped chasing perfection. But he didn’t let falling short turn him into a quitter.

    The missed tackles are annoying. The game losses are dispiriting. The years of relative underperformance are mentally and emotionally taxing.

    But, if you have the right strategy, and you can commit to seeing it through despite – especially through – the tough times, you’ll usually do very, very well, over the long term.

    It is, not surprisingly, the same in investing.

    You can invest like a panicked football club boss.

    Or you can invest like Michael Jordan.

    And the choice you make will make all the difference.

    Fool on!

    The post What the basketball GOAT can teach investors appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Scott Phillips has positions in Berkshire Hathaway. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway. The Motley Fool Australia has recommended Berkshire Hathaway. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Here’s the dividend forecast out to 2028 for Westpac shares

    An excited male investor looks at some Australian bank notes held in his hand with an astounded look on his face

    Owning Westpac Banking Corp (ASX: WBC) shares has typically been a good move for investors focused on dividends. Aside from 2020, amid the COVID impacts, the ASX bank share has provided solid passive income over the past decade.

    The bank is already such a huge business that it can afford to deliver a good dividend payout ratio and still invest in growing its earnings. The market isn’t expecting a lot of growth from Westpac, so its price/earnings (P/E) ratio is not high – that also helps provide a good dividend yield.

    The recent RBA rate hikes may help increase Westpac’s earnings in the shorter-term because it’s able to lend out transaction account balances (which have a low cost for Westpac) at a higher loan interest rate to borrowers.

    Of course, higher rates are not all positive for ASX bank shares – it can increase the risk that some borrowers may default, so keep that in mind.

    Having said all of that, let’s take a look at the dividend projections for owners of Westpac shares for the next two years.

    FY26

    So far in the 2026 financial year, investors have only seen how the ASX bank share performed in the three months to December 2025, being the first quarter of FY26.

    We shouldn’t necessarily expect how the first quarter went to repeat in each of the remaining quarters of FY26. The rate rises by the RBA alone will have an impact. Even so, it’s good to know how the bank performed in that first quarter.

    Westpac reported that its FY26 first-quarter profit was $1.9 billion. Compared to the quarterly average of the second half of FY25, this represented 5% growth, or 6% growth excluding notable items.

    Pleasingly, the bank said that the proportion of new home lending through its own proprietary channel rose for the second consecutive quarter. To me, this likely means it’s capturing more of the lending margin because it’s not losing some of it to a mortgage broker.

    Westpac also said that it saw strong growth in institutional lending and a higher proprietary lending mix in business.

    The bank is also working on its UNITE initiative to make the bank more efficient and hopefully deliver better profit margins.  

    According to the projection on CMC Invest, Westpac paid an annual dividend per Westpac share of $1.605. If that happens, that translates into a grossed-up dividend yield of 5.4%, including franking credits.

    FY27

    Analysts can only guess what will happen to interest rates between now and the end of FY27, which partly depends on how quickly the inflationary situation in the Middle East is resolved.

    But, for now, analysts are predicting that the company’s 2027 financial year annual dividend can increase a little.

    The projection on CMC Invest suggests the ASX bank share could hike its annual payout to $1.64 per Westpac share.

    FY28

    The last year of this series of projections is the 2028 financial year, which could see more slow-and-steady growth for the dividend payout.

    If I were a shareholder, I wouldn’t expect the bank to deliver significant payout growth because of banking competition pressures, but the bank could be capable of providing rising passive income.

    In the 2028 financial year, the ASX bank share could pay an annual dividend per Westpac share of $1.70. That translates into a potential future grossed-up dividend yield of 5.7%, including franking credits.

    The post Here’s the dividend forecast out to 2028 for Westpac shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Westpac Banking Corporation right now?

    Before you buy Westpac Banking Corporation shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Westpac Banking Corporation wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 ASX 200 blue-chip shares worth owning in April 2026

    Person holding a blue chip.

    S&P/ASX 200 Index (ASX: XJO) blue-chip shares could be a smart choice during this volatile, uncertain period. Stability and strength may be a winning combination over the rest of 2026.

    There are some businesses that may well see their earnings increase because of the flow-on effects of the inflation. Even excluding these shorter-term effects, both of the businesses I’m going to talk about have an attractive long-term future, according to experts.

    Experts from the fund manager Wilson Asset Management have picked out two leading ASX 200 blue-chip shares worth owning that are in the WAM Leaders Ltd (ASX: WLE) portfolio, which is a listed investment company (LIC) that targets the “highest quality Australian companies”.

    Let’s take a look at what the experts like about the two businesses and what they’re seeing right now.

    Woodside Energy Group Ltd (ASX: WDS)

    The Woodside share price rose in March as it benefited from the higher oil and LNG prices amid the events in the Middle East and the disruption to the shipping flows in the Strait of Hormuz.

    WAM notes that Woodside has no operations in the affected area, leaving it well positioned to benefit from the supply shock.

    Last month, the ASX energy share also confirmed the permanent appointment of Liz Westcott as managing director and CEO, who reaffirmed the growth strategy, with a focus on project execution and shareholder value creation.

    On top of that, an investor site visit to the Louisiana LNG project affirmed that the development remains “on schedule and on budget”, with de-bottlenecking opportunities identified.

    The fund manager concluded its thoughts on the ASX 200 blue-chip share:

    The company continues to be a key holding in the WAM Leaders investment portfolio with its geographical diversification and pipeline of growth projections positioning the company well in the current environment.

    Ampol Ltd (ASX: ALD)

    The other business that WAM Leaders highlighted is Ampol, which also saw its share price rise during March following higher oil prices and “materially stronger refining margins following the disruption to Middle Eastern oil supply”.

    Refining economics are, according to WAM, “highly sensitive to margin movement”, therefore the near-term refining environment is “expected to improve as global supply tightens and as China restricts diesel and gasoline export contracts from major state refiners”.

    The fund manager also noted that the Australian Government has lifted the fuel security services payment thresholds, providing greater downside protection for the ASX 200 blue chip’s refining business through the cycle.

    The ACCC’s phase 2 review of Ampol’s proposed acquisition of EG Australia’s fuel and convenience retail network also progressed, with sites under review narrowing from 115 to 54. A determination is due by 5 June 2026.

    The post 2 ASX 200 blue-chip shares worth owning in April 2026 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woodside Energy Group Ltd right now?

    Before you buy Woodside Energy Group Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woodside Energy Group Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • GQG Partners share price in focus as Q1 FUM update reveals outflows

    A couple sit in their home looking at a phone screen as if discussing a financial matter.

    The GQG Partners Inc (ASX: GQG) share price is in focus after the fund manager reported total funds under management (FUM) of US$162.5 billion as of 31 March 2026, reflecting net outflows of US$8.6 billion in the first quarter, partially offset by positive investment performance of US$7.3 billion.

    What did GQG Partners report?

    • Total FUM at 31 March 2026: US$162.5 billion, down from US$172.9 billion at the start of March
    • Net outflows: US$1.2 billion for March; US$8.6 billion for the quarter
    • Positive investment performance added US$7.3 billion in the quarter
    • Core strategies (International, Emerging, Global, US) all outperformed their respective benchmarks
    • Fees primarily based on assets managed, with little reliance on performance fees

    What else do investors need to know?

    GQG saw a challenging quarter, with heightened market volatility driven by rising geopolitical and macroeconomic risks. The group’s defensive investment positioning, favouring companies with stable earnings and strong fundamentals, helped all major strategies outperform benchmarks.

    Despite the net outflows, GQG’s management emphasised strong alignment with shareholders and clients. The company remains committed to safeguarding client assets in what they described as a period of substantial downside risk.

    What’s next for GQG Partners?

    Looking ahead, GQG Partners will continue focusing on its defensive investment strategy to help protect against ongoing market uncertainty. The company highlighted a strong alignment of interests between management, shareholders, and clients, supporting a forward-looking, resilient approach.

    Upcoming FUM updates are scheduled for 12 May, 10 June, and 13 July 2026, which will give investors further insight into trends across GQG’s suite of global strategies.

    GQG Partners share price snapshot

    Over the past 12 months, GQG Partners shares have declined 14%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 16% over the same period.

    View Original Announcement

    The post GQG Partners share price in focus as Q1 FUM update reveals outflows appeared first on The Motley Fool Australia.

    Should you invest $1,000 in GQG Partners Inc. right now?

    Before you buy GQG Partners Inc. shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and GQG Partners Inc. wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Gqg Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 5 ASX 200 shares that could be a bargain right now

    Smiling couple looking at a phone at a bargain opportunity.

    It appears sentiment is cautiously optimistic for the ASX 200 as we begin the week. 

    After a tough month in March, Australia’s benchmark index has shown signs of a rebound during April. 

    Last week, the index rose 4.4%, its best weekly gain since October 2022.

    With the tide finally turning for ASX 200 shares, here are 5 that remain significantly below fair value according to broker estimates. 

    CAR Group Ltd (ASX: CAR)

    The CAR Group share price fell 14% in March. However, since late March, it has slowly turned a corner. 

    Investors will be hoping it has reached the bottom of this latest cycle, as investors exited their positions in CAR Group shares largely due to AI replacement fears. 

    It is opening this week at $23.36 per share, which is still 24% lower than the start of 2026. 

    This is significantly below fair price estimates from brokers. 

    Recently, Morgan Stanley reiterated its buy recommendation and placed a $32 price target on the ASX 200 company. 

    This indicates a healthy 37% upside from current levels. 

    CSL Ltd (ASX: CSL)

    CSL has also generated plenty of headlines recently as the ASX 200 stock appears to have been oversold. 

    The biotechnology company has seen its share price fall 19% year to date and more than 40% over the last 12 months. 

    It has reached a point where it is simply too cheap to ignore for many investors, and Bell Potter recently placed a $155 target on the ASX 200 stock. 

    Despite its hold recommendation, this still indicates an upside of 11.5% from current levels. 

    Breville Group Ltd (ASX: BRG)

    Breville Group shares are currently hovering around $28.25, significantly below yearly highs. 

    The consumer discretionary stock fell 16% during March and now appears to be priced at a value. 

    Macquarie recently placed an outperform rating and price target of $37.10 on the ASX 200 stock. 

    This indicates an upside of 31%. 

    JB Hi Fi Ltd (ASX: JBH)

    JB Hi Fi shares are down more than 20% year to date, which included an 11% fall during March. 

    Late last month, Bell Potter retained their buy rating on this retail giant’s shares with a price target of $90.00.

    From last week’s closing price of $75.21, this indicates an upside of nearly 20% for this ASX 200 stock. 

    WiseTech Global Ltd (ASX: WTC)

    Finally, WiseTech shares have been heavily sold off this year amidst AI concerns. 

    The ASX 200 company has seen its share price tumble 45% since the start of 2026. 

    However, it also appears too cheap to ignore. 

    Morgan Stanley recently retained its buy rating for Wisetech with a $70 price target. 

    This suggests an upside potential of 86%. 

    The post 5 ASX 200 shares that could be a bargain right now appeared first on The Motley Fool Australia.

    Should you invest $1,000 in WiseTech Global right now?

    Before you buy WiseTech Global shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and WiseTech Global wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has positions in WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CAR Group Ltd and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Pro Medicus locks in 5-year, $37m Northwestern Medicine contract renewal

    Four smiling young medics with arms crossed stand outside a hospital.

    The Pro Medicus Ltd (ASX: PME) share price is in focus today after the company secured a five-year, $37 million contract renewal with Northwestern Medicine, featuring increased minimum spend and higher fees per transaction.

    What did Pro Medicus report?

    • Signed a 5-year, $37 million contract renewal with Northwestern Medicine
    • The renewal is based on transaction volume, with potential upside
    • Increased minimum commitments and higher fee per exam locked in
    • Nearly $80 million in contract renewals agreed in the past month

    What else do investors need to know?

    The renewed agreement is with Northwestern Medicine, a leading academic health system in Chicago, serving over 200 sites. The contract not only increases the minimum transaction volume but also raises the fee paid to Pro Medicus for each exam, reflecting growth since the initial agreement.

    This contract builds on Pro Medicus’s strong client retention track record. The company’s Visage 7 Viewer platform is now firmly established within Northwestern Medicine, supporting both financial and clinical outcomes.

    What did Pro Medicus management say?

    Chief Executive Officer Dr Sam Hupert said:

    We are extremely pleased that in addition to committing to a second five-year term at an increased fee per exam, NM have also committed to an increase in their minimums reflecting the growth in their exam volumes since standardising on our platform five years ago.

    What’s next for Pro Medicus?

    Pro Medicus continues to invest in its core imaging platform and grow its base of recurring contract revenue. Management highlighted almost $80 million in recent renewals, supporting the company’s belief in the lasting value of its technology.

    The group plans to maintain its focus on client retention and further expansion in international markets, as well as ongoing innovation within its medical imaging software suite.

    Pro Medicus share price snapshot

    Over the past 12 months, Pro Medicus shares have declined 40%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 16% over the same period.

    View Original Announcement

    The post Pro Medicus locks in 5-year, $37m Northwestern Medicine contract renewal appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Pro Medicus right now?

    Before you buy Pro Medicus shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Down 55%, are Xero shares the most overlooked bargain now?

    Man on computer looking at graphs

    Xero Ltd (ASX: XRO) shares have been smashed. The high-growth tech name is down 37% so far in 2026 and a brutal 55% over the past 12 months.

    That’s a dramatic fall for a company that was once a market darling.

    So, is this a warning sign or a rare opportunity? Most brokers seem to think the latter.

    Sticky users, scalable growth

    Let’s start with the fundamentals.

    Xero is a cloud-based accounting platform built for small and medium-sized businesses. It handles invoicing, payroll and financial reporting in one place, making Xero shares a mission-critical tool for its customers.

    And this isn’t some niche player. Xero has built a global footprint across Australia, New Zealand, the UK, and beyond. Its subscription model delivers reliable recurring revenue, while its deep ecosystem of integrations keeps customers locked in. High switching costs. Sticky users. Scalable growth.

    In short, this is still a high-quality business.

    Hit by perfect storm

    So why the heavy sell-off?

    It’s not just Xero shares. The broader tech sector has been under pressure, with names like WiseTech Global Ltd (ASX: WTC) and Technology One Ltd (ASX: TNE) also pulling back. After a strong run in 2025, valuations looked stretched and the market was primed for a reset.

    Then came a new overhang: artificial intelligence (AI).

    Investors started asking whether AI could disrupt traditional software models. Could smarter, cheaper tools reduce the need for subscription platforms like Xero? That uncertainty has weighed heavily on sentiment.

    Add rising interest rates — which tend to hit growth stocks hardest — and you’ve got a perfect storm.

    Bargain hunters on the move

    But here’s where things get interesting.

    After months of selling, Xero shares are now trading well below their previous highs. And that’s starting to turn heads. Bargain hunters are circling, looking to snap up quality growth names at discounted prices.

    The analysts are already leaning that way.

    According to TradingView data, 13 out of 14 analysts rate Xero as a buy or strong buy. Some price targets suggest massive upside, with the most bullish view pointing to $231.35, implying potential gains of up to 225% over the next year.

    Meanwhile, Morgan Stanley has just reiterated its buy rating with a $130 target. That suggests a possible 82% upside from current levels.

    Competition is heating up

    That’s a big disconnect between price and expectations.

    Of course, risks remain. Competition in accounting software is heating up, and any slowdown in subscriber growth or margins could hit the stock. The AI disruption narrative also hasn’t gone away.

    But zoom out, and the long-term story for Xero shares still stacks up.

    Xero has scale. It has recurring revenue. It has sticky customers. And it operates in a massive global market that’s still shifting to the cloud.

    The post Down 55%, are Xero shares the most overlooked bargain now? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has positions in WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Champion Iron finalises acquisition of Norway’s Rana Gruber

    A silhouette shot of two business man shake hands in a boardroom setting with light coming from full length glass windows beyond them.

    The Champion Iron Ltd (ASX: CIA) share price is in focus today as the company announced the successful completion of its voluntary cash tender offer to acquire over 92% of Norway’s Rana Gruber, a high-purity iron ore producer. Champion paid NOK 79 per share, with the total transaction valued at around US$300 million.

    What did Champion Iron report?

    • Acquired 92.48% of Rana Gruber’s issued shares at NOK 79 per share in cash
    • Total purchase price of approximately US$300 million
    • Funded the deal with cash, a US$100 million private placement, and a new US$150 million term loan
    • Expected near-term accretive impact on Champion’s revenue, EBITDA, and cash flows
    • Rana Gruber produced over 1.8 million tonnes of high-purity iron ore in 2025
    • Champion to proceed with compulsory acquisition of remaining shares and delisting Rana Gruber from Euronext Oslo Børs

    What else do investors need to know?

    The Rana Gruber deal broadens Champion Iron’s product portfolio, giving it access to new high-purity hematite and magnetite iron ore concentrate blends. Rana Gruber’s proximity to key European customers complements Champion’s Bloom Lake operations and is set to enhance sales diversification.

    The expanded group will benefit from competitive all-in sustaining costs, access to renewable power, and a strong track record of cash flow generation. Champion has refinanced part of its US$400 million revolving credit facility to support the transaction, with key lenders participating.

    What did Champion Iron management say?

    Champion’s CEO, David Cataford, said:

    The closing of this transaction marks a defining milestone for Champion. Combining our businesses strengthens our leadership as a sustainable supplier of high-purity iron ore produced with a low-carbon footprint, while preserving the culture, expertise, and pride that define both companies. Rana Gruber’s proximity to European customers complements Bloom Lake’s high-purity products and its Direct Reduction Pellet Feed project, currently in the commissioning phase. We look forward to working closely with Rana Gruber’s team to unlock value for our stakeholders and continue to positively impact our host communities.

    What’s next for Champion Iron?

    Champion plans to complete the compulsory acquisition of the remaining shares in Rana Gruber and delist it from the Oslo exchange. Management aims to integrate Rana Gruber, collaborate on sales strategies, and extract synergies from the combined asset base. There’s a shared focus on supporting the green steel sector, further grade improvements, and delivering value to both companies’ communities and employees.

    In the near term, Champion expects the deal to boost its revenue, earnings, and operational cash flow per share while maintaining financial leverage at prior levels.

    Champion Iron share price snapshot

    Over the past 12 months, Champion Iron shares have risen 23%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 16% over the same period.

    View Original Announcement

    The post Champion Iron finalises acquisition of Norway’s Rana Gruber appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Champion Iron Limited right now?

    Before you buy Champion Iron Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Champion Iron Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.